¼¼°è Á¦»êÁ¦ ½ÃÀå
Antacids
»óǰÄÚµå : 1536085
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 486 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,372,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,117,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¦»êÁ¦ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 79¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 68¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Á¦»êÁ¦ ¼¼°è ½ÃÀåÀº 2023-2030³â ºÐ¼® ±â°£¿¡ CAGR 2.2%·Î ¼ºÀåÇϸç 2030³â¿¡´Â 79¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ç¼ºÀÚ ÆßÇÁ ¾ïÁ¦Á¦´Â CAGR 3.7%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. H2 ±æÇ×Á¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 18¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ Á¦»êÁ¦ ½ÃÀåÀº 2023³â 18¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 16¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 4.8%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.5%¿Í 1.6%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è Á¦»êÁ¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

Á¦»êÁ¦´Â À§»êÀ» ÁßÈ­ÇÏ°í °¡½¿ ¾ÎÀÌ, »ê ¿ª·ù, À§½Äµµ ¿ª·ùÁõ(GERD)ÀÇ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ »ç¿ëµÇ´Â »ó¿ë ¾à¹°ÀÔ´Ï´Ù. À§ÀÇ pH °ªÀ» »ó½Â½ÃÅ´À¸·Î½á À§»êÀ» ¾ïÁ¦ÇÏ¿© ¼ÒÈ­ ºÒ·®°ú À§»ê °ú´Ù¿¡ µû¸¥ ºÒÄè°¨À» ¿ÏÈ­ÇÕ´Ï´Ù. Á¦»êÁ¦¿¡ Æ÷ÇԵǴ ÀϹÝÀûÀÎ ¼ººÐÀ¸·Î´Â ¼ö»êÈ­¸¶±×³×½·, ¼ö»êÈ­¾Ë·ç¹Ì´½, ź»êÄ®½·, ź»ê¼ö¼Ò³ªÆ®·ý µîÀÌ ÀÖ½À´Ï´Ù. À̵é È­ÇÕ¹°ÀÇ ÀÛ¿ëÀº °¢°¢ ¹Ì¹¦ÇÏ°Ô ´Ù¸£Áö¸¸, »êÀÇ ÁßÈ­¶ó´Â ±âº»ÀûÀÎ ±â´ÉÀº ¸ðµÎ µ¿ÀÏÇÕ´Ï´Ù. Á¦»êÁ¦´Â Á¤Á¦, ĸ½¶, ¾×ü, ºÐ¸» µî ´Ù¾çÇÑ ÇüÅ·ΠÆÇ¸ÅµÇ°í ÀÖÀ¸¸ç, ¼ÒºñÀÚ¿¡°Ô ´Ù¿ëµµ·Î Æí¸®ÇÑ Á¦Ç°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¦»êÁ¦´Â Á¾Á¾ À§ÀÇ ºÒÄè°¨¿¡ ´ëÇÑ ÃÖÃÊÀÇ ¹æ¾î¼±ÀÌ µÇ´Âµ¥, ½Å¼ÓÇÑ ÀÛ¿ë°ú ÀÔ¼öÀÇ ¿ëÀ̼ºÀ¸·Î ÀαⰡ ÀÖ½À´Ï´Ù.

Á¦»êÁ¦ ½ÃÀåÀº ÀǾà Á¦Á¦ÀÇ Áøº¸·Î ÀÌ·¯ÇÑ Á¦Ç°ÀÇ È¿´É°ú »ç¿ë°¨ÀÌ Çâ»óµÇ¾î ½Ã´ë¿Í ÇÔ²² ÁøÈ­ÇØ ¿Ô½À´Ï´Ù. ÃÖ±ÙÀÇ µ¿ÇâÀ¸·Î´Â Á¦»êÁ¦¿Í ¾Ë±ä»êÀÇ Á¶ÇÕÀÌ ÀÖÀ¸¸ç, ÀÌ´Â À§»êÀ» ÁßÈ­½Ãų »Ó¸¸ ¾Æ´Ï¶ó »êÀÌ ½Äµµ·Î ¿ª·ùÇÏ´Â °ÍÀ» ¸·´Â ¹°¸®Àû À庮À» Çü¼ºÇÕ´Ï´Ù. ¶ÇÇÑ »ý°­, ½ÉȲ, °­ÃÊ »Ñ¸® µîÀÇ Çãºê ¼ººÐÀ» »ç¿ëÇÑ ³»Ãß·²Çϰí À¯±â³ó Á¦»êÁ¦ÀÇ µ¿Çâµµ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, º¸´Ù »ó³ÉÇÑ ¼±ÅÃÀ» ¿ä±¸ÇÏ´Â °Ç°­ ÁöÇâ ¼ÒºñÀÚ¿¡°Ô ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶¾÷ü´Â Á¦»êÁ¦ Á¦Ç°ÀÇ Ç³¹Ì¿Í Áú°¨ °³¼±¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº Á¦Ç°À» ´õ ¼±È£ÇÏ°í ¼·ÃëÇϱ⠽±±â ¶§¹®¿¡ ³ëÀΠȯÀÚ¿Í °°Àº ±âÁ¸ Á¦Á¦¿¡¼­´Â ¼·ÃëÇϱ⠾î·Á¿î ȯÀÚ¿¡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù.

Á¦»êÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è Àα¸ÀÇ À§Àå Àå¾Ö Áõ°¡, ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­, ¼ÒÈ­±â°è °Ç°­À»À§ÇÑ ½ÃÆÇ ¾à¹°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎ½Ä Çâ»ó µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ¸Å¿î À½½Ä, Ä«ÆäÀÎ, ¾ËÄÚ¿ÃÀÇ ´ë·® ¼·Ã븦 Æ÷ÇÔÇÑ ½Ä½À°üÀº ½Å¸À°ú °¡½¿¾ÎÀÌÀÇ ¸¸¿¬¿¡ ±â¿©Çϰí Á¦»êÁ¦ Á¦Ç° ¼ö¿ä¸¦ ºÎÃß±â°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ëÈ­¿¡ µû¸¥ »ý¸®Àû º¯È­·Î ÀÎÇØ ¼ÒÈ­±â°è ¹®Á¦¸¦ ÀÏÀ¸Å°±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡µµ ÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ÇൿÀº ¼¿ÇÁ¸ÞµðÄÉÀ̼ǰú ¿¹¹æÀû °Ç°­°ü¸®·Î ¿Å°Ü°¡°í, Á¦»êÁ¦ÀÇ ¸ÅÃâÀ» ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å¼ÓÇÑ ¿ÏÈ­¿Í ÀûÀº ºÎÀÛ¿ëÀ» Á¦°øÇÏ´Â Á¦Ç° ó¹æÀÇ Çõ½Å, Àû±ØÀûÀÎ ¸¶ÄÉÆÃ Àü·«, ±¤¹üÀ§ÇÑ À¯Åë ä³ÎÀ» ÅëÇØ Á¦»êÁ¦´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼­ ¸Å¿ì Ä£¼÷ÇÑ Á¸Àç·Î ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ÃÆÇµÇ´Â Á¦»êÁ¦¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿øµµ ¾ÈÀü°ú È¿°ú¸¦ º¸ÀåÇϰí, ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ À¯ÁöÇϸç, ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀÌ ÇÔ²² ¼ÒºñÀÚÀÇ ¿ä±¸¿Í °Ç°­ µ¿ÇâÀÇ º¯È­¿¡ ´ëÀÀÇÏ°í ¼ºÀåÀ» °è¼ÓÇÏ´Â °ß°íÇÑ ½ÃÀåÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 54°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Antacids Market to Reach US$7.9 Billion by 2030

The global market for Antacids estimated at US$6.8 Billion in the year 2023, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the H2 Antagonist segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 4.8% CAGR

The Antacids market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Global Antacids Market - Key Trends and Drivers Summarized

Antacids are over-the-counter medications used to neutralize stomach acid and relieve symptoms of heartburn, acid reflux, and gastroesophageal reflux disease (GERD). They work by raising the pH level in the stomach, thereby reducing the acidity and alleviating the discomfort associated with indigestion and sour stomach. Common ingredients in antacids include magnesium hydroxide, aluminum hydroxide, calcium carbonate, and sodium bicarbonate. Each of these compounds works slightly differently, but all serve the same basic function of acid neutralization. Antacids are available in various forms, including tablets, capsules, liquids, and powders, making them versatile and convenient for consumers to use. They are often the first line of defense against occasional stomach discomfort and are popular due to their rapid action and availability.

The market for antacids has evolved over time with advances in pharmaceutical formulations enhancing the effectiveness and user experience of these products. Recent developments include the combination of antacids with alginate, which not only neutralizes stomach acid but also forms a physical barrier that prevents acid from rising back into the esophagus. There is also a growing trend towards natural and organic antacid alternatives that use herbal ingredients such as ginger, turmeric, and licorice root, which appeal to health-conscious consumers looking for gentler options. Additionally, manufacturers have been focusing on improving the flavor and texture of antacid products, which can often be a barrier to compliance for many users. These improvements are designed to make products more palatable and easier to ingest, which is particularly important for elderly patients and others who may have difficulties with conventional formulations.

The growth in the antacids market is driven by several factors, including an increase in gastrointestinal disorders among the global population, lifestyle changes, and enhanced consumer awareness of over-the-counter remedies for digestive health. Dietary habits that include high consumption of spicy foods, caffeine, and alcohol contribute to the prevalence of acidity and heartburn, fueling demand for antacid products. Additionally, the growing elderly population, which is more prone to digestive issues due to physiological changes with aging, also contributes to the expansion of this market. Consumer behavior has shifted towards self-medication and preventive health management, further bolstering the sales of antacids. Furthermore, innovations in product formulations that offer faster relief and fewer side effects, along with aggressive marketing strategies and broad distribution channels, have made antacids highly accessible and popular among consumers. Regulatory support for over-the-counter antacid products also plays a crucial role in ensuring their safety and efficacy, maintaining consumer trust and driving market growth. Together, these factors depict a robust market that continues to adapt and thrive in response to changing consumer needs and health trends.

Select Competitors (Total 54 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â